Skip to search formSkip to main contentSkip to account menu

liraglutide

Known as: N²?-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide, Arg34Lys26-(N-?-(?-Glu(N-?-hexadecanoyl)))-GLP-1[7-37], N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide 
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's… 
National Institutes of Health

Related topics

Related topics

15 relations
3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]3 ML liraglutide 6 MG/ML Pen Injector [Victoza]Glucagon-Like Peptide 1In Blood

Broader (2)

Hypoglycemic AgentsIncretins

Narrower (5)

IDegLiraNN 2211SaxendaVictoza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial
Women with polycystic ovary syndrome (PCOS) were treated with the GLP‐1 receptor agonist liraglutide to investigate the effect on… 
Review
2016
Review
2016
Liraglutide for weight management: a critical review of the evidence
To review the efficacy, safety, and clinical applicability of liraglutide for weight management from phase III clinical trials. 
Highly Cited
2016
Highly Cited
2016
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
OBJECTIVE To investigate whether liraglutide added to treat-to-target insulin improves glycemic control and reduces insulin… 
Highly Cited
2014
Highly Cited
2014
Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes
OBJECTIVE GLP-1 receptor (GLP-1R) agonists induce natriuresis and reduce blood pressure (BP) through incompletely understood… 
Highly Cited
2014
Highly Cited
2014
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial
OBJECTIVE Clinical studies evaluating the effects of medications on β-cell function in type 2 diabetes (T2DM) are compromised by… 
Review
2013
Review
2013
Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
Highly Cited
2012
Highly Cited
2012
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.
The aims of this study were designed to determine whether liraglutide, a long-acting glucagon-like peptide, could reverse the… 
Highly Cited
2012
Highly Cited
2012
Diabetes expenditure, burden of disease and management in 5 EU countries
1 Executive summary 3 1. Background and Objectives 9 Background 9 1.1 Objectives 10 1.2 2. Methodology 11 2.1 Data sources and… 
Highly Cited
2012
Highly Cited
2012
glucagon-like peptide 1 analog liraglutide reduces TNF-- induced oxidative tress and inflammation in endothelial cells
Objective: Glucagon-like peptide 1 (GLP-1), one of the incretin hormones, has been reported to increase positive inotropic… 
Highly Cited
2010
Highly Cited
2010
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)